NIH intends to sole source 4 Cell-IQ CO2 incubators from Esco Technologies.
Some language patterns suggest this RFP may be written for a specific incumbent vendor. Review qualification requirements and brand-specific terms carefully before committing bid resources.
The National Institutes of Health (NIH) intends to award a sole source contract to Esco Technologies, Inc. for four Cell-IQ™ Series 5.8 cu.ft. CO2 Laboratory Incubator units. These incubators are required for cell culture research at the National Cancer Institute (NCI) in Bethesda, MD. The sole source justification is based on the need for compatibility with existing Cell-IQ equipment and software, as well as specific technical features. No other vendors can meet the requirements without significant additional costs and delays. The contract value is not specified.